Table: Fractale -Q1 group results

ADR Biomedical Holdings

10/08/2022 07:01

Aug 10 (Reuters)- 
             Fractale Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            543 mln             461 mln           3.26     
                 (+17.9 pct)        (+216.7 pct)     (+144.1 pct) 
  Operating     loss 162 mln        loss 119 mln        320 mln   
  Recurring     loss 186 mln        loss 104 mln        140 mln   
  Net                                                   20 mln    
  Net           loss 287 mln         loss 93 mln                  
  EPS          loss 32.21 yen      loss 10.69 yen      2.24 yen   
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Fractale Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T